ScholarIQanswers from OpenAlex

Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study

PaperCitations, authors & open-access status

Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study have?

ScholarIQcitation count

Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study has 305 citations in the OpenAlex counts ScholarIQ stores.

When was Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study published?

ScholarIQyear

Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study has 2021 year in the ScholarIQ index.

What is the open-access status of Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study?

ScholarIQoa status

Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study has hybrid oa status in the ScholarIQ index.

What is the DOI of Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study?

ScholarIQdoi

The DOI for Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study is on the source record.

What is the PMID of Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study?

ScholarIQpmid

The PMID for Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study is on the source record.

What is the OpenAlex record for Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study?

ScholarIQopenalex

The OpenAlex for Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial